bowel cancer
3 stories
-
healthZero Relapses in Landmark Bowel Cancer Immunotherapy Trial
Short-course immunotherapy before surgery eliminated relapses in bowel cancer patients over nearly three years.
-
healthImmunotherapy Trial Shows No Cancer Recurrence After Nearly Three Years
A small bowel cancer trial shows pembrolizumab wiped out tumors in 59% of patients. After nearly three years, no recurrence.
-
healthEarly-Onset Bowel Cancer Surges: Actor's Death Sparks Urgent Call for Action
A concerning rise in early-onset bowel cancer among young adults, highlighted by actor James Van Der Beek's death, is driving calls for improved screening and earlier detection strategies.